3246
X.-J. Li et al.
LETTER
pyranose-H), 5.28–5.42 (m, 2 H, pyranose-H). 13C NMR
(125 MHz, DMSO): d = 171.00, 170.86, 170.72, 170.60,
170.04, 169.95, 169.65, 95.60, 82.72, 75.51, 73.77, 72.54,
71.86, 70.19, 69.44, 68.62, 68.13, 62.80, 61.55, 60.60,
56.70, 40.34, 32.76, 29.86, 29.53, 25.06, 24.57, 21.25,
21.08, 21.03, 20.89, 20.82, 20.80, 14.39. IR (KBr): 3354,
2938, 1757, 1542, 1372, 1226, 1046, 940, 906, 754, 601
cm–1. ESI-MS: m/z = 820.22 [M+ + 1].
(15) A Typical Procedure for the Preparation of
Organocatalyst
To a solution of 1, 2-cyclohexyldiamine (3.6 mmol) in
CH2Cl2 (20 mL) was added the corresponding saccharide-
derived isothiocyanates 1 (3 mmol). The mixture was stirred
at r.t. for 3–24 h (TLC) and concentrated. The resulting
residue was purified by flash column chromatography with
the eluent (EtOAc–Et3N, 100:1) to give the crude solid. The
crude solid was dissolved in a minimal amount of CH2Cl2
and slowly precipitated from solution by the addition of PE
at 0 °C. Filtration afforded the desired thiourea products 2.
Compound 2c: yield 55%; mp 90–92 °C; [a]D20 –0.5 (c 1.0,
CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 0.94–1.26 (m,
5 H, cyclohexane-H), 1.66–1.88 (m, 3 H, cyclohexane-H),
1.99 (s, 3 H, COCH3), 2.01 (s, 3 H, COCH3), 2.03 (s, 3 H,
COCH3), 2.05 (s, 3 H, COCH3), 2.24 (s, 6 H, 2 NCH3), 2.32
(m, 1 H, NCH), 3.45 (m, 1 H, NCH), 3.81–3.84 (m, 1 H,
pyranose-H), 4.09–4.12 (m, 1 H, pyranose-H), 4.27–4.31
(m, 1 H, pyranose-H), 4.93–4.97 (t, 1 H, CH2), 5.05–5.09 (t,
1 H, CH2), 5.29–5.33 (m, 2 H, pyranose-H), 5.58–5.60 (br,
1 H, NH), 6.20 (br, 1 H, NH). 13C NMR (125 MHz, CDCl3):
d = 170.85, 170.81, 170.07, 169.85, 83.30, 73.41, 73.5,
73.16, 71.22, 68.50, 61.88, 56.76, 40.46, 32.86, 24.96,
24.58, 22.76, 20.96, 20.94, 20.82, 20.81. IR (KBr): 3352,
2936, 1753, 1542, 1377, 1225, 1035, 910, 758, 601cm–1.
ESI-MS: m/z = 532.26 [M+ + 1].
Compound 2f: yield 24%; mp 92–94 °C; [a]D20 +14.1 (c 1.0,
CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 0.97–1.28 (m,
5 H, cyclohexane-H), 1.54–1.87 (m, 3 H, cyclohexane-H),
1.88–2.25 (m, 27 H, 7 CH3, 2 NCH3), 2.34–2.51 (m, 1 H,
NCH), 3.64–3.71 (m, 1 H, pyranose-H), 3.72–3.89 (m, 2 H,
pyranose-H), 4.00–4.17 (m, 4 H, OCH2), 4.27–4.48 (m, 2 H,
pyranose-H), 4.72–4.87 (m, 1 H, pyranose-H), 4.87–4.93
(m, 1 H, pyranose-H), 5.02–5.09 (m, 1 H, pyranose-H),
5.12–5.27 (m, 1 H, pyranose-H), 5.27–5.31 (m, 1 H,
pyranose-H), 5.42–5.65 (br, 1 H, NH). 13C NMR (125 MHz,
DMSO): d = 170.97, 170.65, 170.54, 170.34, 170.26,
169.29, 169.11, 100.99, 90.16, 74.00, 73.10, 72.34, 71.19,
70.81, 70.77, 69.29, 69.16, 66.89, 66.83, 61.01, 52.66,
40.15, 34.08, 25.44, 24.80, 24.55., 21.04, 21.02, 20.86,
20.83, 20.81, 20.70, 14.38; IR (KBr): 3357, 2938, 1757,
1542, 1372, 1225, 1046, 940, 906, 754, 602 cm–1. ESI-MS:
m/z = 820.19 [M+ + 1].
Compound 2g: yield 38%; mp 158–160 °C; [a]D20 +57.9 (c
1.0, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 0.75–0.88 (t,
12 H, CH3), 0.89–1.72 (m, 8 H, cyclohexane-H), 1.72–2.38
(m, 20 H), 3.78–3.88 (m, 1 H, pyranose-H), 3.97–4.11 (m,
1 H, pyranose-H), 4.31–4.44 (m, 1 H, pyranose-H), 4.89–
5.12 (m, 2 H, CH2), 5.25–5.37 (m, 1 H, pyranose-H), 5.66–
5.83 (m, 1 H, NH), 6.08–6.23 (m, 1 H, pyranose-H), 6.33–
6.61 (m, 1 H, NH). 13C NMR (125 MHz, CDCl3): d = 183.17,
171.38, 170.92, 170.04, 169.89, 82.83, 73.37, 73.14, 70.72,
68.63, 63.84, 61.84, 58.91, 55.05, 32.48, 26.80, 25.85,
24.65, 23.09, 21.36, 20.99, 20.95, 20.83, 20.79. IR (KBr):
3371, 2951, 1751, 1511, 1369, 1232, 1038, 909, 759, 594
cm–1. ESI-MS: m/z = 616.4 [M+ + 1].
Compound 2d: yield 50%; mp 83–86 °C; [a]D20 +4.0 (c 1.0,
CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 1.03–1.30 (m,
4 H, cyclohexane-H), 1.62–1.91 (m, 4 H, cyclohexane-H),
1.99 (s, 3 H, COCH3), 2.01 (s, 3 H, COCH3), 2.03 (s, 3 H,
COCH3), 2.05 (s, 3 H, COCH3), 2.24 (s, 6 H, 2 NCH3), 2.33
(m, 1 H, NCH), 3.45 (m, 1 H, NCH), 3.81–3.84 (m, 1 H,
pyranose-H), 4.09–4.12 (m, 1 H, pyranose-H), 4.27–4.32
(m, 1 H, pyranose-H), 4.91–4.99 (t, 1 H, CH2), 5.04–5.09 (t,
1 H, CH2), 5.30–5.33 (m, 2 H, pyranose-H), 5.58–5.60 (br,
1 H, NH), 6.20 (br, 1 H NH). 13C NMR (125 MHz, CDCl3):
d = 170.86, 170.81, 170.07, 169.86, 83.30, 73.42, 73.16,
71.22, 68.50, 61.88, 56.76, 40.46, 32.86, 24.98, 24.58,
20.96, 20.94, 20.82, 20.81. IR (KBr): 3352, 2939, 1755,
1545, 1378, 1231, 1038, 907, 755, 602 cm–1. ESI-MS: m/z =
532.25 [M+ + 1].
Compound 2h: yield 35%; [a]D20 +23.3 (c 1.0, CH2Cl2).
1H NMR (500 MHz, CDCl3): d = 0.79–0.87 (t, 6 H, CH3),
0.87–1.20 (m, 8 H, CH2), 1.20–1.35 (7 H, cyclohexane-H),
1.63–1.84 (m, 3 H, cyclohexane-H), 1.94–2.08 (q, 12 H,
COCH3), 2.15–2.45 (m, 4 H, NCH2), 3.30–3.65 (m, 1 H,
NH), 3.72–4.34 (m, 3 H, pyranose-H), 4.90–5.71 (m, 4 H,
pyranose-H), 6.35–6.60 (m, 1 H, NH). 13C NMR (125 MHz,
CDCl3): d = 183.16, 171.59, 170.83, 170.0, 169.81, 90.11,
82.81, 73.35, 73.04, 71.08, 68.61, 63.63, 62.09, 55.53,
49.55, 32.79, 31.41, 25.75, 24.68, 23.64, 20.91, 20.90,
20.83, 20.78, 14.28. IR (KBr): 3362, 2933, 1758, 1543,
1377, 1232, 1039, 912, 751, 610 cm–1. ESI-MS: m/z = 616.5
[M+ + 1].
Comound 2e: yield 30%; mp 94–97 °C; [a]D20 +63.0 (c 1.0,
CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 1.15–1.29 (m,
5 H, cyclohexane-H), 1.64–1.84 (m, 3 H, cyclohexane-H),
1.96–2.01 (s, 12 H, 4 COCH3), 2.01–2.04 (s, 3 H, COCH3),
2.04–2.07 (s, 3 H, COCH3), 2.07–2.10 (s, 3 H, COCH3), 2.19
(s, 6 H, 2 NCH3), 2.24–2.38 (br, 1 H, NCH), 2.41–2.92 (br,
1 H, NCH), 3.76–3.82 (d, 1 H, OCH2, J = 7.0 Hz), 3.84–3.89
(d, 1 H, OCH2, J = 10.5 Hz), 3.98–4.04 (d, 2 H, OCH2,
J = 8.0 Hz), 4.04–4.10 (m, 1 H, pyranose-H), 4.16–4.27 (m,
3 H, pyranose-H), 4.42–4.46 (d, 1 H, pyranose-H, J = 12.5
Hz), 4.74–4.82 (m, 2 H, pyranose-H), 5.00–5.07 (m, 1 H,
Synlett 2008, No. 20, 3242–3246 © Thieme Stuttgart · New York